Nov 19, 2024, 02:28
The potential association between AIT and ischaemic cardiotoxicity in postmenopausal women with early Breast Cancer
Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared a post on X:
“Ischaemic cardiotoxicity of aromatase inhibitors in postmenopausal patients with early breast cancer in Denmark: a cohort study of real-world data – The Lancet Oncology
This prospective cohort study from Denmark investigated the potential association between aromatase inhibitor treatment (AIT) and ischemic cardiotoxicity in postmenopausal women with early Breast Cancer.”
Authors: Marie Luna, Giulia Corn, Maj-Britt Jensen, Tonny Petersen, Kim Dalhoff, Bent Ejlertsen, Lars Køber, Jan Wohlfahrt , Mads Melbye
More posts featuring Elisabetta Bonzano.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19